estenosis rate is higher after percutaneous coronary intervention (PCI) for stenosis in small coronary arteries than in large coronary arteries. [1] [2] [3] Although stent implantation has been shown to be a superior strategy to balloon angioplasty, 4, 5 its applicability for small coronary artery disease is controversial. A randomized study, beSMART, 6 showed a significant reduction in angiographic restenosis rate using stents, but was not supported by 2 other comparable randomized studies, the ISAR-SMART 7 and SISA. 8 Although the results of randomized studies are inconclusive, small-size stents are widely used in various clinical situations. Several studies have shown the predictive factors for angiographic restenosis after stent implantation, but the findings can not be applied to small vessels because these data were based on large coronary arteries without complex lesions. [9] [10] [11] The purpose of the present study was to evaluate the clinical, angiographic, and procedural factors in predicting the risk of angiographic restenosis after 2.5-mm stent implantation for small coronary arteries in a consecutive series of patients treated with various coronary stent designs.
Methods
From October 1998 to October 2002, a total of 2,017 consecutive patients underwent coronary intervention at Mitsui Memorial Hospital. Of these, we enrolled subjects according to the following criteria: (1) a reference small coronary artery with a diameter from 1.8 mm to 2.5 mm on quantitative coronary angiography (QCA); and (2) successful treatment by implantation of a 2.5-mm stent. Repeat angiography at 6 months or earlier in the case of symptoms or objective signs of myocardial ischemia was performed in 98%. Finally, we enrolled 134 patients. Angiographic restenosis was defined as greater than 50% diameter stenosis. Patients were classified into 2 groups: 79 patients (79 lesions) without restenosis and 55 patients (55 lesions) with restenosis.
Stent Implantation
We performed provisional stent implantation as the strategy for small coronary artery disease. All patients were pretreated with aspirin and ticlopidine. A bolus of heparin (100 U/kg) was administered before the procedure, with a repeat bolus of 5,000 U given as needed to maintain the activated clotting time greater than 250 s. Target lesions were predilated with conventional angioplasty balloons and 5 types of stents of various designs were inserted using stent-delivery systems [43 Bx velocity stents (Cordis,velocity stent (0.14 mm), AVE GFX, and S660 stent (0.13 mm). Total stent length was defined as sum of the length of all stents implanted.
After stent implantation, high-pressure balloon inflation was performed to achieve a satisfactory angiographic result of <25% residual stenosis by visual estimate. The stent/artery ratio on QCA was calculated by dividing the maximal diameter of the inflated balloon by the reference vessel size. The mean final balloon pressure was 14±3 atm. The mean balloon/artery ratio was 1.15±0.94.
Quantitative Coronary Angiography Analysis
Coronary angiography was carried out in a routine manner. QCA was performed using the automated edge detection system CMS (Medis Medical Imaging Systems, Nuenen, the Netherlands) by experienced interventional cardiologists who were not aware of patient data. QCA was performed before, immediately, and 6 months after the procedure according to edge detection algorithms. Minimal lumen diameter (MLD), reference diameter, diameter of stenosis (DS) and lesion length were measured using a single matched worst view. Acute gain was defined as the MLD immediately after the procedure minus the MLD before procedure.
Statistical Analysis
Statistical analysis was performed using the StatView statistical package (StatView 5, SAS institute, Cary, NC, USA). Difference between groups were evaluated by the chi-square test or the Fisher's exact test for categorical factors and Student's t-test for continuous factors. The analysis of variance test was performed for multiple comparisons. Multiple comparisons were accounted for using the Bonferroni-Dunn method to preserve the overall significance level.
For the main analysis to identity independent predictors of binary restenosis, we used a 2-step analysis.
(1) Univariate analysis was used to select the clinical, angiographic, or procedural factors of angiographic restenosis. Continuous variables were transformed to binary data with 1 for the presence of assumed risk factor and 0 otherwise. We used the median of each factor as the cut-off point for this division, avoiding arbitrary.
(2) Univariate predictors with p<0.05 were entered into a stepwise multivariate logistic regression model. The odds ratio (OR) and 95% confidence intervals (CI) were presented in the table for the final multivariate model. Data are expressed as percent for discrete factors and as mean value ± SD for continuous factors. Statistical significance was accepted for all p-values <0.05. Restenosis rate and target lesion revascularization at 6 months after stent implantation. Rate of angiographic restenosis was 41% and repeat intervention or coronary artery bypass graft surgery was performed in 30.5% and 1.5%, respectively.
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Results
Of the 134 patients, 55 had angiographic restenosis (41%). As shown in Fig 1, the rate of target lesion revascularization at 6 months was 32%; repeat PCI (30.5%) and coronary artery bypass graft surgery (1.5%).
Comparison of Patients With and Without Restenosis
In Table 1 , the clinical, lesional, and procedural-related factors are summarized according to angiographic restenosis. The patients with restenosis had a higher incidence of diabetes mellitus, acute coronary syndrome, bifurcated lesion and had a lower left ventricular ejection fraction (LVEF). The restenosis group also had a longer total stent length and a thicker stent strut. Fig 2 shows the restenosis rate between the thick strut and thin strut groups. Stents with a thick strut had a significantly higher restenosis rate than those with thin struts (29.6% vs 48.8%; p=0.03). A greater stent/artery ratio and a higher final inflation pressure were observed more frequently in the restenosis group.
Angiographic Analysis
Quantitative angiographic measurements are summarized in Table 2 . The restenosis group had a longer lesion length (15.1±8.2 vs 12.3±5.1 mm, p=0.023). Reference vessel, MLD and %DS before the procedure were similar between the 2 groups and although the MLD after procedure was not different, %DS after procedure tended to be lower in the restenosis group.
Univariate and Multivariate Analyses
Several (9 clinical, 6 lesional, 6 procedural, 7 angiographical) factors in relation to angiographic restenosis were analyzed by univariate analysis. As shown in Table 3 , 2 clinical factors (diabetes mellitus, acute coronary syndrome), 3 angiographic factors (longer lesion length, bifurcated lesion, and reduced LVEF ≤40%) and 3 procedural factors (thicker stent strut, bigger stent/artery ratio, and longer stent length) were identified as potential risk factors for restenosis. These 8 factors were entered into a multivariate logistic regression model, which revealed that reduced LVEF (OR 3.73, p=0.01), bifurcated lesion (OR 2.47, p=0.04), thicker stent strut (OR 2.30, p=0.04), and longer stent length (OR 1.05, p=0.02) were significant predictors of in-stent restenosis.
Discussion
Previous studies have reported several factors that can predict restenosis after coronary stenting, including diabetes mellitus, unstable angina, reference diameter, final MLD, and multiple stenting. [9] [10] [11] However, those studies analyzed patients who had the older type of Palmaz-Schatz stents and large coronary vessels without complex lesions. The patients in the present study had complex characteristics that reflected 'real world' cases, including acute coronary syndrome, bifurcated lesions and lower left ventricular (LV) function, and they were treated with contemporary coronary stents that are 2.5 mm in size. In this study, the predictive factors for binary restenosis were identified as reduced LV function, bifurcated lesion, thicker stent strut, and longer stent length.
Pre-Interventional Risk Stratification
Few reports have linked reduced LV function with the development of restenosis. Sawada et al reported that patients with poor LV function who did not fit the STRESS/ BENESTENT criteria had higher restenosis and target lesion revascularization rates. 12 Although an explanation for this relationship was not found, in the present study the patients with reduced LV function had significantly higher incidences of diabetes mellitus, a history of CABG, and multivessel disease than those with normal LV function ( Table 4) . We divided patients in this study into 3 groups, those without diabetes mellitus, those using oral agents and those using insulin, and the rate of restenosis was 32/82 (36.4%), 18/37 (48.6%), and 10/15 (66.7%), respectively. There was no statistically significant difference between patients without diabetes mellitus and those taking oral agents (p=0.06), but those using insulin had a significant higher rate of binary restenosis than patients without diabetes mellitus (p=0.02). Although the incidence of diabetes mellitus in our study disappeared after multivariate analysis, previous studies have reported that diabetes mellitus is a strong predictor of in-stent restenosis, 9-11 which suggests that the high incidence of diabetes mellitus contributed to the high restenosis of patients with reduced LV function in our study.
The incidence of bifurcated lesion was also identified as a strong independent predictor of binary restenosis. Even in the large coronary arteries, PCI of a bifurcation remains a challenging problem. 13 In our study, the use of 2 stents to treat a bifurcated lesion occurred for 17 lesions: 15 treated by T stenting and 2 by Y stenting. The restenosis rate of those techniques was high: 53% and 100%, respectively. The angiographic restenosis rate was 51.4% in 37 bifurcated lesions treated with a single stent. Yamashita et al reported that the restenosis rate after various stent techniques was high for bifurcated lesions of large coronary arteries; 14 their angiographic restenosis rate using 2 stents and 1 stent was 24/39 (62%) and 13/27 (48%), respectively. Apparently, the use of 2 stents for treating bifurcated lesions is associated with poorer outcome compared with 1 stent.
Stent Strut Thickness and Stent Length
Clinical studies have revealed that stent design and stent strut thickness can determine the development of restenosis 15, 16 and the results of our study, which divided the strut thickness into 0.1 mm or more, were in agreement with those reports. However, the data to explain the influence of thicker stent struts on restenosis are lacking. A high degree of vessel stretch, injury and foreign body reaction are important factors for neointimal hyperplasia. 17 In particular, the mechanism of stent-induced damage is vascular injury imposed by the strut, which corresponds to the extent of intimal thickening in experimental animals. 18, 19 Simon et al reported the influence of stent strut on endothelialization of the stented surface, showing that endothelialization capacity is well maintained up to a thickness of 75 m, but beyond that, endothelial cell coverage is impaired. That result explains one of the mechanisms by which a thicker stent is related to the development of restenosis. Injury to endothelial cells and the underlying smooth muscle cells produces experimental neointimal hyperplasia, and denudation of endothelial cells alone produces mild neointimal thickening. 20 
LVEF ≤40%
Normal Effect of stent strut and total stent length on stent restenosis. There were significant differences in the restenosis rates for all subgroups of stent strut for each total stent length (p=0.03). For total stent length ≥20 mm, the restenosis rate (65.2%) with a thicker strut was significantly higher than with a thinner strut (34.8%, p=0.03). For stents with a thicker strut, the restenosis rate with a total stent length ≥20 mm was significantly higher than with a total stent length <20 mm (42.1%, p=0.05). The restenosis rate with both a total stent length ≥20 mm and thicker strut was significantly higher than with both a total stent length <20 mm and a thinner strut (65.2% vs 25.8%, p=0.004).
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We analyzed total stent length as well as the number of stents per lesion. In our study, mean lesion length and stent length were 13.7±6.7 mm and 20.6±9.5 mm, respectively. Our strategy of stent implantation in small coronary arteries was full-covered stenting, but Colombo et al reported that longer stent length was a predictors of stent restenosis and they have been developed the concept of 'spot stenting', in which a stent is placed in the residual stenosis site according to their criterion of using as short a stent as possible. 11, 21 As shown in Fig 3, the present study revealed that the restenosis rate with both longer stent length (≥20 mm) and thicker stent was significantly higher than that with both shorter stent length (<20 mm) and thinner strut (65.2% vs 25.8%, p=0.004). Compared with large coronary arteries, stent implantation in small coronary arteries may easily cause a high degree of vessel stretch and injury. 22 Finally, a smaller MLD is gained. For those reasons, stent factors such as stent length and strut thickness, which provoke neointimal hyperplasia, may be more important factors in small coronary arteries.
Study Limitations
This study was retrospective and may have multiple confounding factors because of being a small, single center study. In addition, there may be selection bias in the analysis of factors. However, we analyzed a number of factors to identify the predictors of restenosis after stent implantation using 2.5-mm stents in small coronary arteries. Finally, intravascular ultrasound data were not available in this study and therefore accurate quantitative analysis of optimal stent expansion was not possible.
Conclusions and Clinical Implications
Small-size stents are widely used in various clinical situations, but in the present study, which used bare-stenting, the rate of restenosis was high at 41%. It is thought that using a bare-stent for the treatment of small coronary arteries has limited applicability, and drug-eluting stents have emerged as the most promising way to treat small vessel disease, [23] [24] [25] and thus solve the problems of restenosis in small vessel disease. As pre-interventional risk stratification factors for the treatment of small vessel disease, reduced LV function and bifurcated lesion were identified as important and drug-eluting stents should be used for patients with these predictive factors. Future studies of drug-eluting stents will clarify the influence on restenosis of the 2 stent factors of length and strut thickness.
